You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Genome-scale De Novo DNA Synthesis on Electronic p-Chips with Sorting

    SBC: Pharmaseq, Inc            Topic: 172

    DESCRIPTION provided by applicant The purpose of the present project is to develop and validate a new method for synthesizing large number of DNA fragments oligodeoxynucleotides The method which is called andquot sequence directed DNA synthesisandquot involves the use of small electronic circuits andquot p Chipsandquot each of which transmits a unique ID number via RF when illuminated w ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  2. Peer mentor training to reduce hospitalizations for children with asthma

    SBC: InquisitHealth, Inc.            Topic: NICHD

    DESCRIPTION provided by applicant The overall goal of this SBIR Fast Track application is to develop a web based program to train peer mentors to guide parents of children with asthma on methods to reduce ED visits and hospitalizations There are million children with asthma Asthma is the cause of million missed days of school million outpatient visits ED visits and ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Developing a Diagnostic Blood Test for Sarcoidosis

    SBC: Sarcoidosis Diagnostic Testing LLC            Topic: NHLBI

    DESCRIPTION provided by applicant SARCOIDOSIS DIAGNOSTIC TESTING LLC is a medical diagnostics company developing a diagnostic blood test for sarcoidosis Sarcoidosis is a multisystem granulomatous disorder that affects per people per year in the U S and disproportionately affects African Americans and women Sarcoidosis can lead to advanced pulmonary fibrosis pulmonary hyperte ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. A new hemagglutination method for blood grouping

    SBC: ALLIED INNOVATIVE SYSTEMS            Topic: NHLBI

    DESCRIPTION provided by applicant The long term goal of the proposed research is to develop a novel quantitative particle agglutination technology for improving the performance of blood typing assays The conventional hemagglutination blood typing assays have serious drawbacks such as limited sensitivity long time of incubation subjectivity and large amount of reagents It is in this context ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Remote Bimanual Virtual Rehabilitation for Elderly with Cerebral Vascular Disease

    SBC: Bright Cloud International Corp            Topic: NIA

    DESCRIPTION provided by applicant The non portable BrightArm Duo prototype is being studied SBIR Phase II grant to Bright Cloud International BCI for Upper Extremity UE motor and cognitive maintenance therapy on CVD survivors who are residents of skilled nursing facilities SNF They train using BCI virtual reality VR bimanual games supervised by an Occupational Therapist The vast ma ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Stable antiinflammatory isothiocyanates from moringa may prevent and treat IBD

    SBC: Nutrasorb LLC            Topic: 213

    DESCRIPTION provided by applicant This Phase I SBIR project aims to preclinically characterize an innovative and proprietary botanical product targeting chronic inflammatory conditions such as inflammatory bowel disease IBD Our objective is to provide experimental support for the hypothesis that anti inflammatory isothiocyanates ITCs naturally produced in the edible leaves of Moringa oleif ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Design Optimization of a Non-degradable Synthetic Device for Cartilage Defects

    SBC: Hydro-Gen LLC            Topic: NIAMS

    DESCRIPTION provided by applicant Trauma and overuse of joints can lead to painful defects in the articular cartilage and underlying bone which adversely affect the mechanical and biological function of the entire joint Over time this early stage damage can spread leading to end stage osteoarthritis OA While treatments for osteochondral defects have been developed to relieve pain and del ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Flow-Measuring Instrument for Improving Outcomes of Endovascular Procedures

    SBC: DVX, LLC            Topic: NHLBI

    DESCRIPTION provided by applicant PAD is a widely prevalent condition affecting of the Medicare population Endovascular procedures such as angioplasty stent are the usual initial surgical procedure close to a million were performed last year Unfortunately many of these procedures fail within a few years In fact less than half of such procedures are successful at two years However ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Genome-scale De Novo DNA Synthesis on Electronic p-Chips with Sorting

    SBC: Pharmaseq, Inc            Topic: 172

    DESCRIPTION provided by applicant The purpose of the present project is to develop and validate a new method for synthesizing large number of DNA fragments oligodeoxynucleotides The method which is called andquot sequence directed DNA synthesisandquot involves the use of small electronic circuits andquot p Chipsandquot each of which transmits a unique ID number via RF when illuminated w ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Use of EF2K inhibitors to inhibit tumor growth and sensitize cancer cells to existing chemotherapy treatment

    SBC: LONGEVICA PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Eukaryotic elongation factor protein kinase eEF K is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an andquot atypicalandquot kinase domain Our recent findings demonstrate that inhibition or genetic inactivation of eEF K protects normal tissues from cytotoxic effects of ionizing radiation and chemotherapeutic ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government